TrialDiabetes care2021

Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial.

Frederik Persson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.